We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$382B
AUM Growth
+$3.03B
(+0.8%)
Cap. Flow
-$4.9B
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
34.7%
Holding
3,317
New
65
Increased
1,141
Reduced
1,398
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$2.55B |
| 2 |
NHYB
Nuveen High Yield Corporate Bond ETF
NHYB
|
+$1.61B |
| 3 |
Apple
AAPL
|
+$732M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$567M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.96B |
| 2 |
NVIDIA
NVDA
|
+$842M |
| 3 |
Amazon
AMZN
|
+$783M |
| 4 |
Microsoft
MSFT
|
+$646M |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$602M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33% |
| 2 | Financials | 12.48% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Vir Biotechnology
VIR
$1.49B
| $3.41M | ﹤0.01% |
565,544
+360,064
| +175% | +$2.14M |
|
2052
Boston Beer
SAM
$1.92B
| $3.4M | ﹤0.01% |
17,440
| – | – |
|
2053
First Advantage
FA
$4.12B
| $3.39M | ﹤0.01% |
233,402
-3,972
| -2% | -$56K |
|
|
UNIT
2054
Uniti Group
UNIT
$2.32B
| $3.39M | ﹤0.01% |
483,440
-87,074
| -15% | -$552K |
|
2055
Algonquin Power & Utilities
AQN
$4.42B
| $3.38M | ﹤0.01% |
549,708
| – | – |
|
2056
Fluence Energy
FLNC
$2.44B
| $3.38M | ﹤0.01% |
171,077
+22,142
| +15% | +$417K |
|
|
SEM
2057
DELISTED
Select Medical
SEM
| $3.38M | ﹤0.01% |
227,663
-442,430
| -66% | -$6.25M |
|
2058
Alkami Technology
ALKT
$2.11B
| $3.38M | ﹤0.01% |
146,544
-155,130
| -51% | -$3.42M |
|
2059
Arcus Biosciences
RCUS
$3.64B
| $3.37M | ﹤0.01% |
141,600
+14,762
| +12% | +$301K |
|
2060
Olin
OLN
$2.12B
| $3.36M | ﹤0.01% |
161,124
-13,339
| -8% | -$288K |
|
2061
ING
ING
$102B
| $3.34M | ﹤0.01% |
119,297
-4,391
| -4% | -$113K |
|
2062
Perrigo
PRGO
$1.78B
| $3.33M | ﹤0.01% |
239,137
+12,603
| +6% | +$210K |
|
2063
EyePoint Inc
EYPT
$1.2B
| $3.31M | ﹤0.01% |
181,256
+76,557
| +73% | +$1.08M |
|
2064
Stoke Therapeutics
STOK
$2.11B
| $3.31M | ﹤0.01% |
104,261
-1,733
| -2% | -$52.1K |
|
2065
Liberty Live Group Series A
LLYVA
$9.09B
| $3.29M | ﹤0.01% |
40,422
| – | – |
|
2066
Interparfums
IPAR
$3.94B
| $3.29M | ﹤0.01% |
38,832
| – | – |
|
2067
Nicolet Bankshares
NIC
$3.62B
| $3.27M | ﹤0.01% |
26,936
-1,211
| -4% | -$153K |
|
2068
Clarivate
CLVT
$1.16B
| $3.26M | ﹤0.01% |
977,269
+19,735
| +2% | +$70.2K |
|
|
FLOC
2069
Flowco Holdings
FLOC
$911M
| $3.25M | ﹤0.01% |
173,660
+95,560
| +122% | +$1.59M |
|
2070
Global E Online
GLBE
$7.11B
| $3.25M | ﹤0.01% |
82,739
| – | – |
|
2071
Peoples Bancorp
PEBO
$1.47B
| $3.22M | ﹤0.01% |
107,375
-47,339
| -31% | -$1.41M |
|
2072
Kingstone Companies
KINS
$276M
| $3.2M | ﹤0.01% |
190,354
-22,546
| -11% | -$343K |
|
2073
Collegium Pharmaceutical
COLL
$956M
| $3.2M | ﹤0.01% |
69,132
-3,021
| -4% | -$126K |
|
2074
Cedar Fair
FUN
$1.67B
| $3.2M | ﹤0.01% |
208,473
+6,100
| +3% | +$110K |
|
2075
Dentsply Sirona
XRAY
$2.43B
| $3.19M | ﹤0.01% |
279,230
+7,447
| +3% | +$87.4K |
|
Similar funds
VFT
Nuveen's Q4 2025 Portfolio in Review
As of Q4 2025, Nuveen held 3,317 positions worth $382B, up 0.8% from $379B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4%. Nuveen opened 65 new positions and exited 67, leaving the 3,317-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q4 2025 buy was TotalEnergies: 5,227,521 shares worth $341M.
- Nuveen added most to Nuveen International Aggregate Bond ETF in Q4 2025, an estimated $2.55B increase.
- Nuveen's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $1.96B.
- Nuveen fully exited Janus Henderson AAA CLO ETF in Q4 2025, selling an estimated $602M.
- Nuveen's ten largest holdings make up 35% of its $382B portfolio in Q4 2025.
- Nuveen opened 65 new positions and closed 67 in Q4 2025.
- Nuveen's portfolio value rose 0.8% quarter-over-quarter to $382B.
Based on Nuveen's 13F filing for Q4 2025, filed 12 Feb 2026.